PillRx only · Tablet · Oral
Bisoprolol Fumarate And Hydrochlorothiazide
Bisoprolol Fumarate + Hydrochlorothiazide
5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
5 active makers
5 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.207
Latest avg · Jul 22, 2026
-1%
Since Dec 17, 2025
5
Active US suppliers
58%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
7.2K
Rx · 2026 Q1
383K
Units dispensed
-25%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it5 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Unichem Pharmaceuticals (USA), Inc. | unknown | 12 | SUPPLYING |
| ANI Pharmaceuticals, Inc. | unknown | 9 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 7 | SUPPLYING |
| Marlex Pharmaceuticals Inc | unknown | 6 | SUPPLYING |
| A-S Medication Solutions | unknown | 2 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Jan 21, 2026RECALLRecall (Class II): Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 2.5 mg/6.25 mg, 100-count bottle, Rx Only, Manufactured by: U…
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits. — Recalling firm: Unichem Pharmaceuticals USA Inc. — US Nationwide and PR.